# A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer

> **NCT02424513** · PHASE2 · WITHDRAWN · sponsor: **ImaginAb, Inc.**

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** [89Zr]Df-IAB2M

## Key facts

- **NCT ID:** NCT02424513
- **Lead sponsor:** ImaginAb, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Clinical trial was postponed as a result of restructured business priorities.
- **Last updated:** 2015-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02424513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02424513, "A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02424513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*